KBC Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Buy
57,563
+1,249
+2% +$243K 0.03% 331
2025
Q4
$9.77M Buy
56,314
+3,560
+7% +$648K 0.02% 358
2025
Q3
$10.1M Sell
52,754
-176
-0.3% -$31.2K 0.02% 354
2025
Q2
$9.51M Buy
52,930
+19,588
+59% +$3.4M 0.03% 369
2025
Q1
$5.64M Buy
33,342
+1,906
+6% +$313K 0.02% 434
2024
Q4
$4.74M Buy
31,436
+1,770
+6% +$275K 0.01% 497
2024
Q3
$4.61M Sell
29,666
-844
-3% -$126K 0.01% 482
2024
Q2
$4.18M Sell
30,510
-14,769
-33% -$2.02M 0.01% 454
2024
Q1
$6.03M Sell
45,279
-29,028
-39% -$3.77M 0.02% 409
2023
Q4
$10.2M Sell
74,307
-8,691
-10% -$1.14M 0.04% 348
2023
Q3
$10.1M Sell
82,998
-8,736
-10% -$1.16M 0.04% 334
2023
Q2
$12.9M Sell
91,734
-24,964
-21% -$3.44M 0.05% 302
2023
Q1
$16.5M Buy
116,698
+66,704
+133% +$9.54M 0.07% 263
2022
Q4
$7.82M Buy
49,994
+7,344
+17% +$1.06M 0.04% 350
2022
Q3
$5.23M Sell
42,650
-1,464
-3% -$193K 0.03% 386
2022
Q2
$5.87M Buy
44,114
+692
+2% +$94.3K 0.03% 373
2022
Q1
$5.94M Sell
43,422
-34,102
-44% -$4.75M 0.02% 401
2021
Q4
$13.4M Sell
77,524
-160,632
-67% -$24.4M 0.04% 309
2021
Q3
$34.6M Sell
238,156
-131,782
-36% -$19.3M 0.13% 189
2021
Q2
$48.8M Buy
369,938
+147,162
+66% +$19.3M 0.09% 235
2021
Q1
$28.6M Sell
222,776
-96,582
-30% -$11.9M 0.06% 315
2020
Q4
$209M Buy
319,358
+169,746
+113% +$20.7M 0.09% 238
2020
Q3
$17.1M Buy
149,612
+113,056
+309% +$13.4M 0.05% 324
2020
Q2
$4.17M Buy
36,556
+19,849
+119% +$2.11M 0.01% 545
2020
Q1
$1.34M Buy
16,707
+2,331
+16% +$241K 0.01% 639
2019
Q4
$1.53M Sell
14,376
-465
-3% -$48.5K 0.01% 756
2019
Q3
$1.59M Hold
14,841
0.01% 718
2019
Q2
$1.51M Hold
14,841
0.01% 696
2019
Q1
$1.33M Hold
14,841
0.01% 755
2018
Q4
$1.24M Sell
14,841
-1,127
-7% -$106K 0.01% 677
2018
Q3
$1.72M Hold
15,968
0.01% 732
2018
Q2
$1.76M Sell
15,968
-55,727
-78% -$5.81M 0.02% 638
2018
Q1
$7.19M Sell
71,695
-23,635
-25% -$2.42M 0.07% 317
2017
Q4
$9.39M Sell
95,330
-115,147
-55% -$10.9M 0.08% 295
2017
Q3
$19.7M Sell
210,477
-2,365
-1% -$251K 0.18% 138
2017
Q2
$23.7M Hold
212,842
0.23% 111
2017
Q1
$20.9M Buy
212,842
+96,778
+83% +$9.23M 0.19% 134
2016
Q4
$10.7M Buy
116,064
+52,942
+84% +$4.56M 0.11% 242
2016
Q3
$5.34M Buy
63,122
+24,107
+62% +$2.02M 0.06% 326
2016
Q2
$3.18M Sell
39,015
-18,698
-32% -$1.42M 0.05% 423
2016
Q1
$4.12M Buy
57,713
+135
+0.2% +$9.05K 0.07% 324
2015
Q4
$4.1M Sell
57,578
-1,473
-2% -$99K 0.08% 306
2015
Q3
$3.63M Sell
59,051
-2,587
-4% -$181K 0.07% 308
2015
Q2
$4.47M Buy
61,638
+50,739
+466% +$3.75M 0.06% 356
2015
Q1
$837K Sell
10,899
-42,397
-80% -$3.04M 0.01% 779
2014
Q4
$3.57M Sell
53,296
-1,285
-2% -$81.1K 0.04% 437
2014
Q3
$3.31M Sell
54,581
-9,568
-15% -$590K 0.12% 241
2014
Q2
$3.77M Buy
64,149
+42,290
+193% +$2.48M 0.04% 451
2014
Q1
$1.27M Sell
21,859
-39,845
-65% -$2.14M 0.02% 604
2013
Q4
$3.3M Sell
61,704
-20,617
-25% -$1.22M 0.05% 393
2013
Q3
$5.09M Sell
82,321
-252
-0.3% -$15.1K 0.08% 303
2013
Q2
$5.01M Buy
+82,573
New +$4.92M 0.09% 277

Other funds holding DGX

KBC Group's DGX Position: Q1 2026 in Review

KBC Group increased its Quest Diagnostics (DGX) stake by 2.2% in Q1 2026, buying an estimated $243K and bringing the position to 57,563 shares worth $11.3M. The position accounts for 0.03% of the portfolio, ranked #331.

KBC Group first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $209M in Q4 2020. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • KBC Group held 57,563 shares of Quest Diagnostics worth $11.3M as of Q1 2026.
  • KBC Group bought 1,249 Quest Diagnostics shares in Q1 2026, an estimated $243K.
  • Quest Diagnostics made up 0.03% of KBC Group's portfolio in Q1 2026, its #331 holding.
  • KBC Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • KBC Group's Quest Diagnostics position peaked at $209M in Q4 2020.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.